Abstract 2781: Prevalence and Characterization of Cerebral Microbleeds in Lacunar Stroke Patients: Observations from the Secondary Prevention Small Subcortical Strokes (SPS3) Trial

Background: The prevalence of cerebral microbleeds (CMBs) has been reported to be high in patients with cerebrovascular disease and particularly in those with cerebral small vessel disease; i.e. lacunar strokes. However, methodological limitations of previous studies imposed by small sample sizes and the absence of a clear classification of stroke subtypes hampers the conclusions regarding prevalence and characterization of CMBs in lacunar stroke patients. Methods: SPS3 is a multi-center international randomized trial including a well-defined cohort of MRI proven lacunar stroke patients. We investigated patients within this population who had an axial T2*- GRE sequence available as part of their baseline clinical MRI. The Brain Observer MicroBleed Scale was used to rate the presence and topography of CMBs. CMB severity was graded as either absent, 1-2 CMBs or >2 CMBs. We compared baseline characteristics and vascular risk factors between patients with CMBs and those without and between the defined CMB severity grades. Results: Of the 651 MRIs analyzed, 237 (36%) had CMBs. Patients with CMBs were more often male (73% vs 62%, p Conclusions: Preliminary results of this large and well-defined cohort of lacunar stroke suggest a high prevalence of CMBs. A significant association was observed between CMBs and gender and a history of lacunar stroke. CMB severity was associated with multiple infarcts and severity of white matter disease on MRI, as well as lower cognitive function. Ongoing data from SPS3 will likely elucidate whether prognosis and response to therapy differ in patients with CMBs.